Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
This story is reported by Intellia Therapeutics. Read what other outlets are saying below, then open the original report for full details.